RecallDepth
Class II Ongoing

Valsartan Tablets 40 mg USP, 30 tablet bottles, Rx, Only, Distributed by: Acetris Health, LLC, Saddle Brook, NJ, Manufactured by: Aurolife Pharma LLC, Dayton, NJ ---- NDC 52343-122-30

Company
Rising Pharmaceuticals, Inc.
Recall Initiated
March 7, 2019
Posted
March 27, 2019
Recall Number
D-1052-2019
Voluntary / Mandated
Voluntary: Firm initiated
Quantity
30,530 bottles
Firm Location
Saddle Brook, NJ, United States

Reason for Recall

CGMP Deviations; Detection of a trace amount of unexpected impurity N- nitrosodiethylamine (NDEA) found in finished products

Distribution

Product was distributed to 6 major distributors who may have further distributed the product throughout the United States.

Lot / Code Info

470170038A, exp. date 10/31/2019 470180010A, exp. date 02/29/2019 470180012A, exp. date 03/31/2020

More recalls by Rising Pharmaceuticals, Inc.

View all recalls by this company →

Other recent Class II Drug recalls